Serum bilirubin and risk of respiratory disease and death

JAMA

Volumn 305, Issue 7, 2011, Pages 691-697

  Horsfall, Laura J ^a   Rait, Greta ^a,b   Walters, Kate ^a   Swallow, Dallas M ^a   Pereira, Stephen P ^a   Nazareth, Irwin ^a,b   Petersen, Irene ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DEATH; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 79951712620     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.124     Document Type: Article

References (31)

1. Bosma PJ, Chowdhury JR, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med. 1995;333(18):1171-1175.
2. Lin JP, Vitek L, Schwertner HA. Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Clin Chem. 2010;56(10):1535-1543.
3. Lin R, Wang X, Wang Y, et al. Association of polymorphisms in four bilirubinmetabolism geneswith serum bilirubin in three Asian populations. Hum Mutat. 2009;30(4):609-615.
4. Fredenburgh LE, Perrella MA, Mitsialis SA. The role of heme oxygenase-1 in pulmonary disease. Am J Respir Cell Mol Biol. 2007;36(2):158-165. (Pubitemid 46233468)
5. Ryter SW, Morse D, Choi AM. Carbon monoxide and bilirubin: potential therapies for pulmonary/vascular injury and disease. Am J Respir Cell Mol Biol. 2007;36(2):175-182. (Pubitemid 46233470)
6. Bourke A, Dattani H, Robinson M. Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care. 2004;12(3):171-177. (Pubitemid 39534583)
7. Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract. 2010;60(572):e128-e136.
8. Booth N. What are the Read Codes? Health Libr Rev. 1994;11(3):177-182.
9. Wilding P, Rollason JG, Robinson D. Patterns of change for various biochemical constituents detected in well population screening. Clin Chim Acta. 1972;41:375-387.
10. Lin JP, O'Donnell CJ, Schwaiger JP, et al. Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation. 2006;114(14):1476-1481. (Pubitemid 44527002)
11. Davé S, Petersen I. Creating medical and drug code lists to identify cases in primary care databases. Pharmacoepidemiol Drug Saf. 2009;18(8):704-707.
12. Lewis JD, Bilker WB, Weinstein RB, Strom BL. The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf. 2005;14(7):443-451. (Pubitemid 40990739)
13. Temme EH, Zhang J, Schouten EG, Kesteloot H. Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Causes Control. 2001;12(10):887-894. (Pubitemid 34048869)
14. Zucker SD, Horn PS, Sherman KE. Serum bilirubin levels in the US population: gender effect and inverse correlation with colorectal cancer. Hepatology. 2004;40(4):827-835. (Pubitemid 39288115)
15. Djoussé L, Levy D, Cupples LA, Evans JC, D'Agostino RB, Ellison RC. Total serum bilirubin and risk of cardiovascular disease in the Framingham Offspring Study. Am J Cardiol. 2001;87(10):1196-1200, A4, 7.
16. Marston L, Carpenter JR, Walters KR, Morris RW, Nazareth I, Petersen I. Issues in multiple imputation of missing data for large general practice clinical databases. Pharmacoepidemiol Drug Saf. 2010;19(6):618-626.
17. Maguire A, Blak BT, Thompson M. The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf. 2009;18(1):76-83.
18. Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med. 2006;25(1):127-141. (Pubitemid 43136953)
19. Campbell M, Swinscow T. Statistics at Square One. Chichester, England: John Wiley & Sons; 2009.
20. Harrell F. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY: Springer-Verlag; 2001.
21. Novotný L, Vítek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med (Maywood). 2003;228(5):568-571. (Pubitemid 37203679)
22. Thanassoulis G, O'Donnell CJ. Mendelian randomization: nature's randomized trial in the post-genome era. JAMA. 2009;301(22):2386-2388.
23. Beutler E, Gelbart T, Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci U S A. 1998;95(14):8170-8174. (Pubitemid 28326085)
24. Premawardhena A, Fisher CA, Liu YT, et al. The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications. Blood Cells Mol Dis. 2003;31(1):98-101. (Pubitemid 36802250)
25. Van Hoydonck PG, Temme EH, Schouten EG. Serum bilirubin concentration in a Belgian population: the association with smoking status and type of cigarettes. Int J Epidemiol. 2001;30(6):1465-1472. (Pubitemid 34134309)
26. Hong AL, Huo D, Kim HJ, et al. UDP-Glucuronosyl-transferase 1A1 gene polymorphisms and total bilirubin levels in an ethnically diverse cohort of women. Drug Metab Dispos. 2007;35(8):1254-1261. (Pubitemid 47121764)
27. Census 2001: General Report for England and Wales. Newport, Wales: Office for National Statistics; 2005.
28. Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci U S A. 1988;85(24):9748-9752. (Pubitemid 19027202)
29. Rappaport SM, Smith MT. Environment and disease risks. Science. 2010;330(6003):460-461.
30. Wild CP. Complementing the genome with an "exposome": the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005;14(8):1847-1850.
31. Chen YH, Chau LY, Chen JW, Lin SJ. Serum bilirubin and ferritin levels link heme oxygenase-1 gene promoter polymorphism and susceptibility to coronary artery disease in diabetic patients. Diabetes Care. 2008;31(8):1615-1620.